MSB 3.42% $1.21 mesoblast limited

Cell Therapy News/Articles, page-5700

  1. 3,152 Posts.
    lightbulb Created with Sketch. 331
    Yeh that is definitely some sloppy writing and misreporting.

    "The readout in September is for 90 patients assuming 45 treated with placebo and 45 treated with Rem-L."

    Am I right in thinking the split between treated and placebo could go any way seeing as it's randomised?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.